Foreign Exchange And Guidance RiskA modest foreign-exchange headwind alongside maintained guidance highlights limited margin for error if currency moves or other cost pressures intensify.
News Sensitivity And Investor SentimentHigh sensitivity to oral GLP news flow keeps many investors in a wait‑and‑see stance, increasing volatility around regulatory, clinical, or launch updates.
Product Adoption RiskUncertainty around the pace and magnitude of oral GLP adoption, beginning with orforglipron, could constrain revenue if patient uptake or market acceptance proves slower than anticipated.